Adults younger than 65 now account for 45% of all newly diagnosed colorectal cancer cases in the U.S., up from 27% in 1995, according to the American Cancer Society’s “Colorectal Cancer Statistics, 2026” report published March 2 in CA: A…
The Latest
Stanford (Calif.) Cancer Institute has tapped Vivek Subbiah, MD, as inaugural associate director for drug development and precision oncology. Dr. Subbiah was also appointed as executive medical director for cancer novel therapies and clinical trial network development at Stanford (Calif.)…
For decades, oncology programs have measured success by volume, speed and five-year survival rates. Ten cancer leaders told Becker’s these benchmarks are increasingly disconnected from what matters most: timely, equitable access to evidence-based treatment and outcomes that reflect both survival…
Starting specialty therapy can involve navigating as many as nine separate platforms.For health systems, medical centers and hospital pharmacies, that fragmentation slows treatment initiation and complicates coordination across stakeholders. In oncology, even small delays can carry significant clinical and operational…
Apr 1, 2026 11:00 PM - 12:00 PM CDT
Presented by:
Presenters
Miranda Delatore, DNP, RN, NEA-BC
Vice President, Product, CoverMyMeds
Molly M. Brady, RN, BSN
Director of Customer Success, Ontada
Jakob Emerson
Managing Editor, Becker’s Healthcare
A team from the University of California San Diego has collaborated on the development of an AI model to improve the precision of prostate cancer radiation therapy. The AI tool matched or outperformed human experts at mapping the urethra on…
Co-located multidisciplinary clinics — where newly diagnosed cancer patients meet with all of their cancer specialists on the same day — can expedite time to treatment, reduce costs and improve outcomes, according to a study published Feb. 20 in the…
Behavioral health can no longer function as a crisis-only service line. Health systems are confronting the limits of episodic models that intervene too late, fragment care and strain emergency departments. As value-based expectations grow, leaders are redesigning behavioral health to…
Mar 24, 2026 1:00 PM - 2:00 PM CDT
Presented by:
Presenters
Scott Domingue, DNP, MBA, RN, NEA-BC
Chief Operating Officer and Chief Nursing Officer, Texas Health Resources
Tami Lew-Ahrendt, MA CCT, PHR, SHRM-CP
President and Chief Executive Officer, CenterPointe
Laura Bauer
VP Strategy, Iris Telehealth
A team at Philadelphia-based Fox Chase Cancer Center has developed a patient education program aimed at improving clinical trial enrollment. The multidisciplinary team created the program after interviewing and collaborating with kidney cancer patients, according to a Feb. 26 news…
Houston Methodist has tapped Daniela Matei, MD, as director of the Dr. Mary and Ron Neal Cancer Center. Dr. Matei will step into the role in April, according to a Feb. 27 news release from Houston Methodist. She currently serves…
BeOne Corporate Video
Sponsored
BeOne Medicines is a global oncology company discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of novel therapeutics through its internal capabilities and…